» Articles » PMID: 17344916

Expression of the JAK2 V617F Mutation is Not Found in De Novo AML and MDS but is Detected in MDS-derived Leukemia of Megakaryoblastic Nature

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2007 Mar 9
PMID 17344916
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Changing histopathological diagnostics by genome-based tumor classification.

Kloth M, Buettner R Genes (Basel). 2014; 5(2):444-59.

PMID: 24879454 PMC: 4094942. DOI: 10.3390/genes5020444.


Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemias.

Guerrouahen B, Futami M, Vaklavas C, Kanerva J, Whichard Z, Nwawka K Clin Cancer Res. 2010; 16(4):1149-58.

PMID: 20145167 PMC: 2988651. DOI: 10.1158/1078-0432.CCR-09-2416.


Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status.

Raya J, Arenillas L, Domingo A, Bellosillo B, Gutierrez G, Luno E Int J Hematol. 2008; 88(4):387-395.

PMID: 18820995 DOI: 10.1007/s12185-008-0169-1.


Whole genome scanning as a cytogenetic tool in hematologic malignancies.

Maciejewski J, Mufti G Blood. 2008; 112(4):965-74.

PMID: 18505780 PMC: 2515145. DOI: 10.1182/blood-2008-02-130435.